Growth Metrics

Rigel Pharmaceuticals (RIGL) Share-based Compensation (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 25.76%
Dec 31, 2025 -18.29%
Sep 30, 2025 2.66%
Jun 30, 2025 -1.44%
Mar 31, 2025 59.27%
Dec 31, 2024 -21.07%
Sep 30, 2024 4.59%
Jun 30, 2024 -50.76%
Mar 31, 2024 165.60%
Dec 31, 2023 -0.51%
Sep 30, 2023 -10.54%
Jun 30, 2023 -21.25%
Mar 31, 2023 -32.40%
Dec 31, 2022 50.72%
Sep 30, 2022 13.22%
Jun 30, 2022 -25.44%
Mar 31, 2022 37.11%
Dec 31, 2021 6.22%
Sep 30, 2021 -4.51%
Jun 30, 2021 -12.62%
Mar 31, 2021 61.90%
Dec 31, 2020 -13.48%
Sep 30, 2020 7.23%
Jun 30, 2020 -13.19%
Mar 31, 2020 43.44%
Dec 31, 2019 -32.75%
Sep 30, 2019 -20.92%
Jun 30, 2019 -10.16%
Mar 31, 2019 43.56%
Dec 31, 2018 -31.32%
Sep 30, 2018 169.33%
Jun 30, 2018 -27.79%
Mar 31, 2018 -49.66%
Dec 31, 2017 250.40%
Sep 30, 2017 -20.64%
Jun 30, 2017 15.18%
Mar 31, 2017 -13.18%
Dec 31, 2016 -35.82%
Sep 30, 2016 -14.90%
Jun 30, 2016 40.06%
Mar 31, 2016 -11.51%
Dec 31, 2015 -10.47%
Sep 30, 2015 -4.92%
Jun 30, 2015 -7.06%
Mar 31, 2015 36.93%
Dec 31, 2014 -27.88%
Sep 30, 2014 -2.44%
Jun 30, 2014 -9.81%
Mar 31, 2014 51.25%
Dec 31, 2013 553.97%
Sep 30, 2013 -86.32%
Jun 30, 2013 -2.57%
Mar 31, 2013 -45.05%
Dec 31, 2012 0.55%
Sep 30, 2012 7.77%
Jun 30, 2012 -2.81%
Mar 31, 2012 1.87%
Dec 31, 2011 -1.59%
Sep 30, 2011 -3.44%
Jun 30, 2011 -16.60%
Mar 31, 2011 0.95%
Dec 31, 2010 0.90%